Screening of vesicoureteral reflux in pediatric patients with kidney transplantation showing non-specific interstitial fibrosis and tubular atrophy with interstitial Tamm-Horsfall protein deposits in protocol allograft biopsy

Clinical Transplantation

Volumn 23, Issue SUPPL. 20, 2009, Pages 2-5

  Akioka, Yuko ^a   Chikamoto, Hiroko ^a   Horita, Shigeru ^a   Yago, Rie ^a   Tanabe, Kazunari ^a   Yamaguchi, Yutaka ^b   Hattori, Motoshi ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Horsfall protein; Interstitial fibrosis and tubular atrophy; Interstitial inflammation; Tamm; Vesicoureteral reflux

Indexed keywords

BASILIXIMAB; CALCINEURIN INHIBITOR; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RITUXIMAB; TAMM HORSFALL GLYCOPROTEIN;

ADOLESCENT; ADULT; CELL INFILTRATION; CHILD; CHRONIC PYELONEPHRITIS; CLINICAL ARTICLE; CONFERENCE PAPER; CYSTOURETHROGRAPHY; DISEASE CLASSIFICATION; DISEASE MARKER; DISEASE SEVERITY; GRAFT RECIPIENT; HISTOPATHOLOGY; HUMAN; INTERSTITIAL FIBROSIS AND TUBULAR ATROPHY; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY FIBROSIS; KIDNEY PARENCHYMA; KIDNEY TRANSPLANTATION; MONONUCLEAR CELL; PRIORITY JOURNAL; SCORING SYSTEM; SCREENING; URINARY TRACT INFECTION; URINE FLOW RATE; VESICOURETERAL REFLUX;

ADOLESCENT; ATROPHY; BIOPSY; BLOOD GROUP ANTIGENS; CHILD; CHILD, PRESCHOOL; FIBROSIS; FOLLOW-UP STUDIES; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; KIDNEY TUBULES; MUCOPROTEINS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; UROGRAPHY; VESICO-URETERAL REFLUX;

EID: 67650648710     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2009.01000.x     Document Type: Conference Paper

References (14)

1. S olez K, C olvin RB, R acusen LC et al. Banff'05 meeting report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy. Am J Transplant 2007: 7: 518.
2. Shigematsu H, Murakami S. Intrarenal reflux and nephropathy. Jpn J Nephrol 1990: 32: 87.
3. International Reflux Committee. Medical versus surgical treatment of primary vesicoureteral reflux: Report of the International Reflux Study Committee. Pediatrics 1981: 67: 392.
4. Schedl A. Renal abnormalities and their developmental origin. Nat Genet 2007: 8: 791.
5. Berger RM, Maizels M, Morgan GC et al. Bladder capacity (ounce) equals age (years) plus 2 predicts normal bladder capacity and aids in diagnosis of abnormal voiding patterns. J Urol 1983: 129: 347.
6. Hoyer JR. Tubulointerstitial immune complex nephritis in rats immunized with Tamm-Horsfall protein. Kidney Int 1980: 17: 284.
7. Bailey RR, Swainson CP, Torres VE. Vesicoureteral reflux and reflux nephropathy. In: S chrier RW eds. Kidney & Urinary Tract, 8th edn. Philadelphia: Lippincott Williams & Wilkins Press, 2007: 650.
8. Orskov I, Ferencz A, Orskov F. Tamm-Horsfall protein or uromucoid is the normal urinary slime that traps type 1 fimbriated Escherichia coli. Lancet 1980: 315: 887.
9. Dupont P, Psimenou E, Lord R et al. Late recurrent urinary tract infections may produce renal allograft scarring even in absence of symptoms or vesicoureteric reflux. Transplantation 2007: 84: 351.
10. Ranchin B, Chapuis F, Dawhara M et al. Vesicoureteral reflux after transplantation in children. Nephrol Dial Transplant 2000: 15: 1852.
11. Molina G, Feritosa LC, Martin X et al. Incidence of vesicoureteral reflux after allograft renal transplantation. Transplant Proc 1994: 26: 292.
12. Herthelius M, Oborn H. Bladder dysfunction in children and adolescents after renal transplantation. Pediatr Nephrol 2006: 21: 725.
13. Mengel M, Gwinner W, Schwarz A et al. Infiltrates in protocol biopsies from renal allografts. Am J Transplant 2007: 7: 356.
14. Solez K, Colvin RB, Racusen LC et al. Banff 07 classification of renal allograft pathology: Updates and future directions. Am J Transplant 2008: 8: 753.